Press Release

Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast

November 5, 2019 at 8:31 AM EST

BOSTON--(BUSINESS WIRE)--Nov. 5, 2019-- Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Wednesday, November 13, 2019, at 4:30 p.m. ET to review its third quarter 2019 financial results and provide an update on the company.

The webcast will be available on the “Investors” section of the Gamida Cell website at To participate in the live call, please dial 866-930-5560 (domestic) or 409-216-0605 (international) and refer to conference ID number 8653335. A replay of the webcast will be available approximately two hours after the event, for approximately 30 days.

About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion platform to develop product candidates designed to expand the possibility of cell therapy. For additional information, please visit

Source: Gamida Cell Ltd.

Jaren Irene Madden

Krystle Gibbs (media)